Literature DB >> 17028200

Regulatory T cell-mediated suppression: potential role of ICER.

Josef Bodor1, Zoltan Fehervari, Betty Diamond, Shimon Sakaguchi.   

Abstract

How regulatory T (TR) cells dampen T cell responses remains unclear. Multiple modes of action have been proposed, including cell contact-dependent and/or cytokine-dependent mechanisms. Suppression may involve direct contact between TR cells and responder T cells. Alternatively, TR cells may act on dendritic cells to reduce their ability to prime T cells by modulating costimulation, inducing the secretion of suppressive cytokines or the increase of tryptophan metabolism. Here, we review emerging, novel mechanisms involved in contact-dependent, TR-mediated suppression of IL-2 production in responder CD25- T lymphocytes and the potential involvement of inducible cAMP early repressor (ICER) in this suppression. Finally, cytokines such as TGF-beta and IL-10, produced by TR cells or other cells, may exert local suppression, which can be conveyed by basic mechanism(s) acting in a similar manner as contact-dependent, TR-mediated suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028200     DOI: 10.1189/jlb.0706474

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  The complement receptor CD46 tips the scales in T(H)1 self-control.

Authors:  Christian M Karsten; Jörg Köhl
Journal:  Nat Immunol       Date:  2010-09       Impact factor: 25.606

2.  Hormonal regulation of thymic-stage differentiation of IL-17-producing and T-regulatory lymphocytes.

Authors:  S V Shirshev; E G Orlova; S A Zamorina; I V Nekrasova
Journal:  Dokl Biol Sci       Date:  2014-03-22

3.  Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP.

Authors:  Jinghong Li; Ko-Wei Lin; Fiona Murray; Takeshi Nakajima; Yandong Zhao; David L Perkins; Patricia W Finn
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-28       Impact factor: 6.914

4.  Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques.

Authors:  Shulin Qin; Beth A F Junecko; Carissa M Lucero; Cynthia R Klamar; Anita M Trichel; Michael A Murphey-Corb; Patrick M Tarwater; Denise E Kirschner; Todd A Reinhart
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

5.  Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.

Authors:  Ai-Xia Dou; Li-Li Feng; Xiao-Qian Liu; Xin Wang
Journal:  Cell Mol Immunol       Date:  2012-09-24       Impact factor: 11.530

6.  Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation.

Authors:  Alberto Baroja-Mazo; Beatriz Revilla-Nuin; África de Bejar; Laura Martínez-Alarcón; José I Herrero; Ali El-Tayeb; Christa E Müller; Pedro Aparicio; Pablo Pelegrín; José A Pons
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

Review 7.  Developmental biology of the innate immune response: implications for neonatal and infant vaccine development.

Authors:  Victoria Jane Philbin; Ofer Levy
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

8.  Molecular mechanisms of treg-mediated T cell suppression.

Authors:  Angelika Schmidt; Nina Oberle; Peter H Krammer
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

9.  Boosting regulatory T cell function by CD4 stimulation enters the clinic.

Authors:  Christian Becker; Tobias Bopp; Helmut Jonuleit
Journal:  Front Immunol       Date:  2012-06-18       Impact factor: 7.561

10.  Modulation of Phenotype and Function of Human CD4+CD25+ T Regulatory Lymphocytes Mediated by cAMP-Elevating Agents.

Authors:  Antonella Riccomi; Valentina Gesa; Alessandra Sacchi; Maria Teresa De Magistris; Silvia Vendetti
Journal:  Front Immunol       Date:  2016-09-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.